JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rindler, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rindler, M. J.

J Biol Chem, Vol. 273, Issue 47, 31180-31185, November 20, 1998


Carboxypeptidase E, a Peripheral Membrane Protein Implicated in the Targeting of Hormones to Secretory Granules, Co-aggregates with Granule Content Proteins at Acidic pH*

Michael J. RindlerDagger

From the Department of Cell Biology and Kaplan Cancer Center, New York University Medical Center, New York, New York 10016

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Carboxypeptidase E (CPE) is a prohormone-processing enzyme and peripheral membrane protein of endocrine/neuroendocrine secretory granules. CPE has been shown to bind to an amino-terminal peptide of pro-opiomelanocortin (N-POMC) at pH 5.5 and hypothesized to be critically involved in the targeting of hormones such as POMC to the regulated secretory pathway [Cool, D. R., Normant, E., Shen, F., Chen, H. C., Pannell, L., Zhang, Y., and Loh, Y. P. (1997) Cell 88, 73-83]. To further explore the possibility that CPE serves to mediate the association of content proteins with the membrane during granule biogenesis, the binding of CPE to granule content proteins was investigated using an in vitro aggregation assay in which the selective precipitation of granule content proteins is induced by titration of the pH to <6.0. CPE was observed to co-aggregate efficiently with pituitary and chromaffin granule content proteins at concentrations well below those that promote its self-aggregation. In addition, CPE co-precipitated at pH 5.8 with purified prolactin and with insulin, which homophillically self-aggregate yet are structurally distinct from N-POMC. N-POMC when added to the assays did not inhibit the aggregation of CPE with prolactin or insulin, indicating that these interactions do not involve a binding site for N-POMC. The data show that CPE interacts at acidic pH with a variety of different content proteins, resembling in this regard other granule membrane proteins. The results support the idea that co-aggregation of abundant membrane proteins with content proteins is an important general mechanism for the sorting and retention of secretory granule proteins during granule maturation.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Aggregation of secretory granule proteins occurs as immature secretory granules (ISGs)1 are formed from the trans-Golgi network (TGN) and continue to mature and acidify (1, 2). Aggregation can also be achieved by lowering the pH of isolated granule contents, including those derived from chromaffin and anterior pituitary granules (3) as well as pancreatic zymogen granules (4, 5). A number of purified granule content proteins, including the chromogranins A and B (in the presence of calcium) (6, 7), prolactin (3), and insulin (8), aggregate in vitro as the pH is lowered to <6.5 as well, reinforcing the view that changes in the ionic milieu of the TGN and ISG are responsible for content protein condensation (9, 10). Constitutively secreted proteins such as albumin and IgG, when added to content proteins, do not precipitate, suggesting that the formation of aggregates itself may directly regulate the process of segregating constitutively secreted proteins from granule content proteins (3).

We have previously demonstrated that the luminal domains of several abundant granule membrane proteins can co-aggregate with content proteins at pH 5.5-6 (3), which mimics the conditions existing in the ISG, a site where sorting of proteins destined for storage from those constitutively secreted is known to occur (11-13). This would be consistent with the idea that membrane and content proteins use similar routes of segregation during granule maturation and that the binding of content proteins to the granule membranes is mediated by the major membrane proteins themselves. Recently, Cool et al. (14) showed that pro-opiomelanocortin (POMC) as well as a peptide consisting of its amino-terminal 26 amino acids (N-POMC) bind to pituitary secretory granule membranes with a pH optimum of 5.5-6. This peptide was chosen because the amino-terminal portion of POMC can confer granule targeting on heterologous proteins in transfected cells (15). The binding of N-POMC to membranes was inhibited not only by POMC itself but by proinsulin and proenkephalin, suggesting that common sites of association are used by several different hormones. N-POMC could also be cross-linked at pH 5.5 to carboxypeptidase E (CPE), an abundant granule membrane protein (14), suggesting that POMC binding to membranes was mediated by CPE. Moreover, in cells depleted of CPE, either from the pituitary of fat/fat mice, which bear a mutation in CPE that prevents its exit from the endoplasmic reticulum (16, 17), or in cells transfected with antisense DNA constructs, POMC was observed to be secreted largely by the constitutive pathway (14). These data were interpreted to mean that CPE serves as the sorting receptor for POMC and other related prohormones, although the hypothesis remains controversial as proinsulin incorporation into secretory granules was not greatly affected in either isolated islets or an insulin-secreting cell line derived from fat/fat mice (18, 19).

CPE is a processing enzyme found in all endocrine and neuroendocrine cells (20). It associates with membranes at low pH by virtue of an amphipathic helix in its carboxyl terminus (21), resembling in this regard other processing enzymes such as prohormone convertase 2, which has a membrane binding domain in its amino terminus (22). CPE undergoes homophillic self-association at pH 5.5 when present at high concentrations (23), another property shared by prohormone convertase 2 (22) and by the luminal segment of peptidyl glycine alpha -amidating mono-oxygenase (3). In the current study, we have evaluated the interaction of CPE with granule content proteins using low pH-induced aggregation as an assay. The results indicate that CPE has the capacity to interact with granule content proteins other than prohormones as pH is titrated to the range of the TGN and ISG. Thus, in its ability to interact with content proteins, CPE resembles other membrane-associated proteins including peptidyl glycine alpha -amidating mono-oxygenase, dopamine beta -hydroxylase, and pancreatic glycoprotein 2 (3, 5), suggesting that these interactions are important in the segregation of granule membrane and content proteins during granule formation and maturation.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Antibodies and Purified Granule Content Proteins-- Purified bovine CPE (mixture of membrane forms) and rabbit antibodies specific for the amino- and carboxyl-terminal peptides were generously provided by Dr. L. Fricker (Albert Einstein College of Medicine, Bronx, NY) and were prepared as reported previously (23). Rabbit antibodies to chromogranin B (CgB) were a gift from Dr. R. Angeletti (Albert Einstein College of Medicine). Rabbit IgG, bovine insulin, and ovine prolactin (Prl) were purchased from Sigma. Human growth hormone (GH) was obtained from the National Institute of Diabetes and Digestive and Kidney Diseases National Hormone and Pituitary Program, whereas rabbit antibody was purchased from Accurate Chemical (Westbury, NY). N-POMC, synthesized by Phoenix Pharmaceuticals (Mountain View, CA), was a gift from Dr. Y.-P. Loh (National Institutes of Health, Bethesda, MD).

Preparation of Granule Content Proteins-- Bovine adrenal chromaffin and pituitary granules were prepared as described previously (3). Granules were lysed by freeze-thawing and sonication in 100 mM KCl, 25 mM HEPES, pH 7.5, in the presence of protease inhibitors. The released content proteins were recovered from the supernatant after centrifugation and desalted on Bio-Gel P-6 DG columns (Bio-Rad).

In Vitro Aggregation Assay-- The assay was conducted as described previously (3). In brief, 50-µl samples containing granule content or the proteins of interest in 5 mM HEPES, 10 mM 4-morpholineethanesulfonic acid, pH 7.5, and 0.016% Triton X-100, with KCl or CaCl2 where indicated, were centrifuged for 30 min, and the pellet was discarded. The supernatants were then titrated slowly to the indicated pH values by adding 0.125 N HCl while vortexing. The pH was measured with a microelectrode (Microelectrodes Inc., Bedford, NH). CPE was generally used at a concentration of 1.3 µg/ml, which is well below the threshold necessary to induce self-aggregation at this pH (23). GEMSA (Calbiochem) was added in some experiments after the prespin and 20 min before pH titration. After incubation for 30 min at 23 °C., the reaction mixture was centrifuged to separate the precipitates from the supernatant fractions. Centrifugation in most cases was for 30 min at 15,000 × g in an Eppendorf centrifuge. In experiments in which adrenal chromaffin extracts were incubated in the presence of calcium, centrifugation was conducted at 56,000 × g in a TL100 ultracentrifuge, which is required for efficient recovery of CgA (3). CPE aggregation itself could be induced at concentrations of 40 µg/ml, with pellets recovered by centrifugation at 100,000 × g as described (23). A portion of the supernatant and the entire pellet fractions were then subjected to immunoblotting (see below). As a control, samples were subjected to pH titration but not centrifuged. Under the conditions used, the amounts of protein remaining in the tubes after removal of the assay mixture were inconsequential (data not shown). Triton X-100 at 0.016% had no effect on overall aggregation of pituitary or adrenal extracts but did prevent binding of CPE itself to the tubes. To measure insulin aggregation, pellets and supernatants from triplicate samples were subjected to a Micro-BCA assay (Pierce), as described previously (3).

To assess the effect of N-POMC on CPE aggregation with Prl or insulin, a modification of the assay protocol was used. The final sample volume was reduced to 25 µl, and a buffer of 5 mM HEPES, 20 mM 4-morpholineethanesulfonic acid, 130 mM KCl, and 0.016% Triton X-100 was used. After the prespin, N-POMC (120 µg/ml final concentration) or an equivalent volume of 5 mM HEPES was added, and after a 15-min incubation the pH was reduced to 5.8. After an additional 30 min at 37 °C, centrifugation was conducted at 100,000 × g for 30 min. This protocol allowed titration of the amount of hormone necessary to induce reproducible CPE co-aggregation to 40 µg/ml for insulin and 80 µg/ml for Prl. The aggregation of Prl and insulin was essentially identical at 23 and 37 °C (data not shown).

Immunoblotting-- Immunoblotting was performed after SDS-PAGE, transfer of the proteins to nitrocellulose paper, and staining with Ponceau S to visualize the transferred proteins. In experiments in which IgG was used, SDS-PAGE was performed without a reducing agent. Antibodies directed against the amino terminus of CPE were used in the experiments shown, but carboxyl-terminal antibodies were used in initial experiments with the identical results. All antibodies were generally used at a 1:500-1:2000 dilution. The enhanced chemiluminescence procedure was used with preflashed film to visualize the reactive species (Amersham Pharmacia Biotech). The exposed radiographs and the images of gels stained with Ponceau S were digitized (LACIE Ltd., Beaverton, CA) and imported into Quark Express (Denver, CO) for computerized labeling and printing of figures. Quantitation of aggregation on the scanned images was conducted using NIH Image (version 1.55) on exposures that were not oversaturated. All of the data presented are representative experiments that were repeated two to four times with similar results.

Measurement of CPE Activity-- The assays of CPE activity were performed using the method of Fricker and Devi (24). In brief, purified CPE was diluted (1:500) in 0.1 M NaOAc, pH 5.5, 0.01% Triton X-100, 10 µg/ml bovine serum albumin, and 1 mM CoCl2 and incubated at 4 °C. for 20 min in the presence or absence of 0.5 µM GEMSA. Dansyl-FAR (20 µM) was then added, and the reaction was allowed to continue for 7 min at 37 °C and 5 min. at 4 °C before addition of HCl (0.15 M final concentration) and chloroform. After centrifugation, samples were read in a Perkin-Elmer 650-10S fluorescence spectrophotometer using excitation and emission wavelengths of 355 and 500 nm, respectively. All assays were conducted in triplicate.

    RESULTS
Top
Abstract
Introduction
Procedures
Results
Discussion
References

CPE Aggregates Together with Other Pituitary and Adrenal Chromaffin Granule Proteins-- CPE is an endogenous protein of the pituitary gland (20) and was readily detectable in granule content prepared from bovine pituitary (Fig. 1). To assess whether CPE could interact with pituitary content proteins, an in vitro aggregation assay was used (3). This assay allows the measurement of weak but specific protein-protein interactions at mildly acidic pH that are difficult to detect by more direct procedures. The pH of pituitary extracts was slowly acidified, and CPE was detected by immunoblotting. As shown in Fig. 1, CPE aggregated effectively (>90%) at pH 5.8 but remained almost entirely in the unaggregated supernatant at pH 7.5. Similarly, as we have previously demonstrated (3), other pituitary content proteins, including Prl and GH, aggregate as the pH is reduced. This observation was not a consequence of the homophillic self-aggregation of CPE, which is known to occur at pH 5.5 and high concentrations of protein (23). CPE alone at levels (1.3 µg/ml) comparable with those present endogenously (1.5 µg/ml estimated from densitometric scanning) in the pituitary samples (Fig. 1, compare lanes 2 and 10), did not aggregate either at pH 7.5 or pH 5.8 (<= 1% in this experiment, never >6% in any experiment). However, addition of exogenous CPE (membrane form) to the pituitary extract led to the precipitation (>90%) of both endogenous and exogenous CPE (Fig. 1, lanes 7 and 8). Quantitative assessment of CPE aggregation in the pH range 5.4-7.5 is shown in Fig. 1 (right panel). CPE aggregation was more efficient than that of Prl and GH with a half-maximal value ~6.0. Although our gel system did not completely separate the different forms, much of the endogenous CPE would be expected to be in a soluble form lacking its amphipathic membrane anchor (23). Thus, the data indicate that both soluble and membrane forms have the ability to co-aggregate with content proteins in this assay.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   CPE co-aggregates with pituitary granule content proteins at pH 5.8. Left panels, pituitary granule content (1 mg/ml) was incubated either alone (lanes 1-4) or with purified CPE (1.3 µg/ml) added (Pit + CPE, lanes 5-8) using the standard assay conditions (see "Experimental Procedures"). CPE was incubated in the absence of granule content as a control (lanes 9-12). The pH was reduced as indicated. The entire pellet (P; odd numbered lanes) and 20% of the remaining supernatant (S) after centrifugation (even numbered lanes) were then subjected to SDS-PAGE and transfer to nitrocellulose paper. CPE (top panels) was identified by immunoblotting, whereas the major pituitary content proteins Prl and GH were visualized by staining with Ponceau S (bottom panels). Right panel, the assay was performed as described above, but in this case, equal aliquots (50%) of the supernatant and pellet samples were used for SDS-PAGE and immunoblotting. CPE in the pituitary pellet (open circle ) or incubated alone (triangle ) is depicted along with Prl and GH bands quantitated after staining the bottom portion of the gels with Coomassie Blue (). Each data point represents the mean and S.E. of three to six samples from three separate experiments.

CPE was also detectable in the adrenal granule extracts but at much lower levels (Fig. 2). Surprisingly, both endogenous CPE and exogenously added CPE were recovered primarily (>70% in this experiment) in the pellet fractions when the pH of the chromaffin granule content was titrated to 5.8 even in the absence of CaCl2, which is required for the aggregation of the major content protein CgA (Fig. 2, lanes 3, 4, 9, and 10). Bands on the gels corresponding to CgB, however, were detected in the pH 5.8 pellet fractions both by Ponceau staining (Fig. 2, bottom) and by immunoblotting (data not shown), as were unidentified high molecular weight proteins (Fig. 2, arrowheads). As expected, CPE itself did not undergo appreciable aggregation when incubated alone at pH 7.5 or pH 5.8 in the presence or absence of CaCl2, and neither the endogenous nor the added CPE was recovered in the pellet fractions at pH 7.5. Similar results were obtained even when the centrifugation was performed at 15,000 × g, which was used to generate the quantitative assessment of CPE aggregation shown in Fig. 2 (bottom right). The half-maximal value for aggregation of CPE was ~5.8 in the adrenal extracts under these conditions. Thus, CPE is able to interact with aggregating chromaffin granule content proteins, perhaps including CgB.


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 2.   CPE aggregates with adrenal granule content proteins at pH 5.8. Chromaffin granule content (1 mg/ml) was incubated either alone (lanes 1-6) or with CPE added (lanes 7-12). CPE was incubated in the absence of granule content as a control (lanes 13-18). Samples were incubated and analyzed as described in Fig. 1, except that the precipitate was recovered by centrifugation at 56,000 × g for 30 min. CaCl2 (25 mM) was included in one set of samples to induce aggregation of CgA (lanes 5, 6, 11, 12, 17, and 18). Bands corresponding to CgB as well as other unidentified high molecular weight proteins (arrowheads) recovered in the pellet fractions at pH 5.8 are also indicated. Bottom right panel, adrenal extracts with CPE added were subjected to pH titration and analysis as described above in the absence of added CaCl2 and with recovery of the pellet fractions at 15,000 × g. CPE in the adrenal pellet (open circle ) or incubated alone (triangle ) is depicted. Total protein was determined from computerized images of the nitrocellulose paper stained with Ponceau S (). Each data point represents three samples from two separate experiments. P, pellet; S, supernatant.

The interaction of CPE with granule content proteins was not dependent on its enzymatic activity. GEMSA, an inhibitor of CPE (24), which at this concentration (0.5 µM) decreased the activity of purified CPE by >95% (data not shown), had no effect on the co-aggregation of CPE together with pituitary content proteins (Fig. 3A). Moreover, the interaction of CPE with granule content proteins occurred just as readily at physiological salt concentrations. Inclusion of 140 mM KCl in the reaction mixture had no effect on the extent of CPE aggregation (Fig. 3B). Similar results were obtained in two separate experiments with >95% aggregation of CPE occurring under each set of conditions at pH 5.8. 


View larger version (51K):
[in this window]
[in a new window]
 
Fig. 3.   Low pH induced aggregation of CPE with the pituitary granule content proteins is not dependent on its enzymatic activity and occurs at physiological salt concentrations. A, 0.5 µM GEMSA, an inhibitor of CPE activity, was added to sample mixtures 20 min before titration to pH 5.8 (lanes 3 and 4). B, the aggregation assay was performed at pH 5.8 without added KCl (lanes 1 and 2) or in the presence of 140 mM KCl (lanes 3 and 4). The assays were performed and the samples were analyzed as described in Fig. 1. Top panels, CPE alone; middle panels, aggregation of CPE; bottom panels, aggregation of Prl and GH under the same conditions. P, pellet; S, supernatant.

Similar results were obtained for CPE aggregation in adrenal extracts (Fig. 4). GEMSA did not affect aggregation of CPE significantly (mean, 65%; range, 61-68% for control versus 63%; range, 56-69% for GEMSA; n = 2). The addition of KCl did lower the efficiency of aggregation somewhat, but the effects were small, with the amount of CPE in the pellets decreasing from 74% without salt to 65% with KCl (Fig. 4) or from 42 to 32% in another experiment (data not shown).


View larger version (77K):
[in this window]
[in a new window]
 
Fig. 4.   Low pH induced aggregation of CPE with the chromaffin granule content proteins is not dependent on its enzymatic activity and occurs at physiological salt concentrations. Aggregation assays in the presence of 0.5 µM GEMSA (A) or 140 mM KCl (B) were also performed using adrenal chromaffin granule content with exogenous CPE (1.3 µg/ml) added (lanes 3 and 4). In each case, parallel assays were conducted under the standard conditions (lanes 1 and 2). The aggregation assays were performed exactly as described in Fig. 3, i.e. in the absence of added CaCl2 and with centrifugation at 15,000 × g. Top panels, purified CPE alone; middle panels, CPE aggregation in the adrenal extract; bottom panels, aggregation of the chromaffin granule content proteins. P, pellet; S, supernatant.

CPE Co-precipitates with Prolactin and Insulin-- Prolactin is the major component of the pituitary granule extracts. We have previously shown that Prl self-aggregates as the pH is titrated to <6.5 (3). It was therefore of interest to determine whether CPE and Prl could interact directly. CPE was incubated with Prl as the pH was titrated to 5.8. As shown in Fig. 5, in the absence of Prl, CPE did not aggregate appreciably (<= 4%) at either pH (lanes 1 and 3), whereas in the presence of Prl, CPE was recovered almost exclusively in the supernatant at pH 7.5 (99%) and in the pellet at pH 5.8 (mean, 95%; range, 94-97%; n = 2) together with Prl (mean, 47%; range, 42-52; n = 2). This interaction also was observed in the presence of 140 mM KCl (data not shown), indicating that the interaction is relatively strong.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 5.   CPE co-precipitates with prolactin. CPE was incubated in the aggregation assay in the presence (bottom panels) or absence (top panels) of Prl, which homophillically self-aggregates at mildly acidic pH. The pH was titrated to 5.8 where indicated (lanes 3 and 4). Pellet (P, odd numbered lanes) and supernatant (S, even numbered lanes) samples were collected and analyzed as described in Fig. 1, with CPE identified by immunoblotting and Prl by Ponceau S staining (bottom).

The interaction of CPE with insulin, another hormone that undergoes self-aggregation at acidic pH (8), was also assessed. Insulin aggregates effectively as pH is titrated to <6.5. In fact, >99% of insulin is recovered in the pellet fraction at pH 5.8 under our standard assay conditions (data not shown). It proved necessary, however, to include 140 mM KCl in the assay mixtures to effectively prevent IgG, a marker of the constitutive secretory pathway, from co-aggregating to some extent. Fig. 6 shows the results of an experiment in which CPE and IgG were mixed with insulin. In the absence of insulin, CPE did not aggregate significantly at either pH (Fig. 6, lanes 1 and 3), whereas in the presence of insulin, CPE was recovered exclusively in the supernatant at pH 7.5 (Fig. 6, lane 5) and at pH 5.8 (Fig. 6, lane 7), primarily in the pellet (81 ± 6%; n = 3). IgG remained almost entirely in the supernatant even in the presence of insulin (Fig. 6, lanes 5 and 7, bottom panels). The amount of insulin aggregation could not be directly quantitated using SDS-PAGE. However, in experiments conducted in the absence of added CPE and measuring total protein recoveries, 64 ± 3% (n = 3) of insulin was found in the pellet fraction under these assay conditions.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 6.   CPE co-precipitates with insulin. CPE (top panels) was incubated in the aggregation assay (with 140 mM KCl added) in the absence (lanes 1-4) or presence (lanes 5-8) of bovine insulin (1 mg/ml). As a control for nonspecific binding, rabbit IgG (1.5 µg/ml), a constitutively secreted protein that should not interact with insulin, was incubated in the absence (lanes 1-4) or presence (lanes 5-8) of insulin in another series of tubes (bottom panels). The pH was titrated to 5.8 where indicated (lanes 3, 4, 7, and 8), which induces of insulin to precipitate. Pellet (P, odd numbered lanes) and supernatant (S, even numbered lanes) samples were collected and analyzed as described in Fig. 1, with CPE and IgG identified by immunoblotting.

N-POMC Does Not Inhibit the Aggregation of CPE with Prolactin or Insulin-- As noted in the Introduction, CPE has been shown to bind to a peptide corresponding to the amino-terminal 26 amino acids of POMC at pH 5.5 (14). The question therefore arises of whether CPE has a single binding site capable of interacting with a number of different hormones, including Prl and insulin. To test this hypothesis, N-POMC was included in the assays together with CPE before pH titration. To maximize the ratio of the peptide to the precipitating hormones, much lower amounts of insulin (40 µg/ml) and Prl (80 µg/ml) were used, and the assay protocol was modified to recover a higher proportion of the aggregates (see "Experimental Procedures"). Fig. 7 shows that under these conditions CPE when incubated alone remained in the supernatant fraction (<= 6%) in the presence or absence of N-POMC (top panel). In the presence of insulin (Fig. 7, middle panel), CPE aggregated well in the absence or presence of the peptide (88 versus 80%, respectively, in this experiment; 95 versus 97% in a second experiment). Similarly, in the presence of Prl (Fig. 7, bottom panel) the amount of CPE recovered in the pellet was not affected by N-POMC (56 without versus 59% with peptide in this experiment; 86 versus 93% in a second experiment). It should be pointed out that N-POMC was present in ~5-fold molar excess in the case of insulin, ~11-fold in the case of Prl, and in >1500-fold excess of CPE itself. Hence we conclude that the sites of interaction of CPE with Prl and insulin are distinct from any involved in its binding to N-POMC.


View larger version (63K):
[in this window]
[in a new window]
 
Fig. 7.   N-POMC does not inhibit the interaction of CPE with insulin or prolactin. CPE (1.3 µg/ml) was incubated either alone (top panels) or with 40 µg/ml insulin (middle panels) or 80 µg/ml Prl (bottom panels). N-POMC (120 µg/ml) was included in one set of samples (lanes 3 and 4), whereas in the other set an equal volume of buffer was included (lanes 1 and 2). The pH was reduced in all samples to 5.8, and precipitates were recovered by centrifugation at 100,000 × g for 30 min. The entire pellet (P) and in this case 50% of the supernatant (S) fractions were then subjected to SDS-PAGE and immunoblotting as described in Fig. 1.


    DISCUSSION
Top
Abstract
Introduction
Procedures
Results
Discussion
References

Acidification is thought to play a critical role in secretory granule formation. Incubation of secretory cells with high concentrations of lysosomotropic amines (2, 25-28) or with bafilomycin A1 (29), an inhibitor of vacuolar ATPases, leads to inefficient packaging of granule content proteins as well as inefficient prohormone processing and ISG maturation. The aggregation of CPE with granule proteins from pituitary and adrenal gland is a measure of its ability to bind to content proteins and is consistent with a role for acidic pH in the interaction of content proteins with the membrane during granule formation. The pH dependence in vitro is consistent with initiation of aggregation in the environment of the TGN (5.9-6.2) (30, 31), with the process continuing even more vigorously in ISGs (5.5-6) (2). Given the fact that the concentrations of content proteins are much higher (>100 mg/ml) in secretory granules than those used in our assay,2 it is reasonable to propose that stronger and more significant interactions between CPE and granule content proteins would take place in vivo in the TGN, where protein concentration would also be expected to be high.

An unexpected observation was that CPE aggregated well in the chromaffin granule extracts in the absence of added calcium at pH 5.8. CgB and higher molecular weight components were also present in the precipitates, and we have previously shown that dopamine beta -hydroxylase partially aggregates under these conditions (~50% of the calcium induced precipitation) (3). The formation of aggregates containing content and membrane components during acidification of the secretory organelles, as occurs in vitro, is consistent with a pH-dependent protein sorting mechanism involving condensation of granule components. Indeed, these findings are consistent with the observations made in streptolysin-permeabilized PC12 cells, in which neutralization of pH interfered with the sorting of chromogranin C to secretory granules (32).

As noted in the Introduction, CPE has been postulated to be a "sorting receptor" having a direct role in chaperoning certain hormones to secretory granules (14, 33). Evidence that N-POMC can be directly cross-linked to CPE in granule membranes was interpreted as reflecting a receptor-ligand interaction. Because N-POMC has a disulfide loop that is also found in other prohormones such as proenkephalin and proinsulin, and these prohormones inhibit the binding of N-POMC to granule membranes, a common binding site in CPE for this type of motif was postulated to mediate the sorting of these proteins (14). The interaction of CPE with additional granule content proteins, as shown in this study, would be consistent with a role for CPE as a broad spectrum chaperone that could mediate the interaction of a variety of content proteins with membranes during granule biogenesis, particularly as aggregation was occurring. It is important to note, however, that the binding of CPE to Prl, which is structurally unrelated to POMC, and to insulin, which lacks the C peptide and does not have a complete disulfide loop, was unaffected by N-POMC, indicating that CPE has more than one binding site for content proteins.

Recent studies using pancreatic islets (18) or insulin-secreting cell lines derived from fat/fat mice (19) contradict the view that CPE is critical for peptide hormone storage. In both cases, constitutive release of proinsulin was not enhanced in cells with defective CPE, whereas regulated secretion of partially processed insulin and proinsulin remained robust, and immature-looking secretory granules were also present (16, 19). These results indicate that CPE is not required for proinsulin targeting but is necessary for processing and condensation.

Given the conflicting observations, what is the significance of the specific interactions of CPE with granule proteins, and what role might these interactions play, if any, in promoting content protein storage? Noteworthy in this regard is the fact that a number of other membrane proteins share with CPE the ability to bind content proteins at pH 5.5-6. These include dopamine beta -hydroxylase, which co-precipitates with chromaffin granule content proteins (3), peptidyl glycine alpha -amidating mono-oxygenase, which co-aggregates with chromaffin and pituitary granule content (3), glycoprotein 2, which specifically co-aggregates with pancreatic zymogens (5) and binds polymerized amylase (34), and an inositol triphosphate receptor/calcium channel, which has been reported to bind to CgA at acidic pH (35). Moreover, several granule membrane proteins self-aggregate at acidic pH. One is CPE (23), and another is prohormone convertase 2 (22), which also have amphipathic helices that mediate their membrane binding. The integral membrane proteins peptidyl glycine alpha -amidating mono-oxygenase (3) and glycoprotein 2 (36) can self-associate as well. The association of membrane proteins with themselves and perhaps their neighbors in the plane of the membrane could provide a scaffold for the binding and envelopment of aggregating content proteins in the TGN and ISG. The specific interaction of CPE with some granule content proteins and with other membrane-associated processing enzymes, as has been reported (37), is consistent with this model. Hence processing enzymes, which represent major granule membrane components (38), could subserve roles both in peptide hormone generation and, in concert with other major membrane proteins, as the "receptors" for the selective membrane recruitment, segregation, and retention of content proteins as their aggregation is initiated by acidic pH. In pancreatic beta cells, depletion of a single membrane component such as CPE may have little effect, but in other cell types, such as neuro 2A, CPE may represent a higher proportion of the membrane proteins and potentially could play a more significant role.

    ACKNOWLEDGEMENTS

I thank G. Kicska, M. Jackson, and Y. Jin for expert technical assistance, Dr. D. Sabatini for continued encouragement and support, Dr. Y.-P. Loh for the gift of N-POMC, and Drs. L. Fricker and L. Devi for generously providing reagents and advice.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grant DK44238 and by the American Heart Association, New York City affiliate.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 212-263-5812; Fax: 212-263-8139; E-mail: rindler{at}mcrcr.med.nyu.edu.

The abbreviations used are: ISG, immature secretory granule; TGN, trans-Golgi network; CPE, carboxypeptidase E/H; GH, growth hormone; Prl, prolactin; CgA and CgB, chromogranins A and B; POMC, pro-opiomelanocortin; N-POMC, amino-terminal 26 amino acids of POMC; PAGE, polyacrylamide gel electrophoresis; GEMSA, 2-guanidinoethylthiosuccinic acid.

2 M. Rindler, unpublished observation.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results
Discussion
References

  1. Jamieson, J. D., and Palade, G. E. (1971) J. Cell Biol. 48, 503-522[Abstract/Free Full Text]
  2. Orci, L., Ravazzola, M., Amherdt, M., Madsen, O., Perrelet, A., Vassalli, J. D., and Anderson, R. G. (1986) J. Cell Biol. 103, 2273-2281[Abstract/Free Full Text]
  3. Colomer, V., Kicska, G. A., and Rindler, M. J. (1996) J. Biol. Chem. 271, 48-55[Abstract/Free Full Text]
  4. Leblond, F. A., Viau, G., Laine, J., and Lebel, D. (1993) Biochem. J. 291, 289-296
  5. Colomer, V., Lal, K., Hoops, T. C., and Rindler, M. J. (1994) EMBO J. 13, 3711-3719[Medline] [Order article via Infotrieve]
  6. Gorr, S. U., Dean, W. L., Radley, T. L., and Cohn, D. V. (1988) Bone Miner 4, 17-25[Medline] [Order article via Infotrieve]
  7. Yoo, S. H., and Albanesi, J. P. (1991) J. Biol. Chem. 266, 7740-7745[Abstract/Free Full Text]
  8. Steiner, D. F. (1973) Nature 243, 528-530[CrossRef][Medline] [Order article via Infotrieve]
  9. Huttner, W. B., and Tooze, S. A. (1989) Curr. Opin. Cell Biol. 1, 648-654[CrossRef][Medline] [Order article via Infotrieve]
  10. Rindler, M. J. (1992) Curr. Opin. Cell Biol. 4, 616-622[CrossRef][Medline] [Order article via Infotrieve]
  11. Kuliawat, R., and Arvan, P. (1992) J. Cell Biol. 118, 521-529[Abstract/Free Full Text]
  12. Grimes, M., and Kelly, R. B. (1992) J. Cell Biol. 117, 539-549[Abstract/Free Full Text]
  13. Castle, A. M., Huang, A. Y., and Castle, J. D. (1997) J. Cell Biol. 138, 45-54[Abstract/Free Full Text]
  14. Cool, D. R., Normant, E., Shen, F., Chen, H. C., Pannell, L., Zhang, Y., and Loh, Y. P. (1997) Cell 88, 73-83[CrossRef][Medline] [Order article via Infotrieve]
  15. Tam, W. W. H., Andreasson, K. I., and Loh, Y. P. (1993) Eur. J. Cell Biol. 62, 294-306[Medline] [Order article via Infotrieve]
  16. Naggert, J. K., Fricker, L. D., Varlamov, O., Nishina, P. M., Rouille, Y., Steiner, D. F., Carroll, R. J., Paigen, B. J., and Leiter, E. H. (1995) Nat. Genet. 10, 135-142[Medline] [Order article via Infotrieve]
  17. Varlamov, O., Leiter, E. H., and Fricker, L. (1996) J. Biol. Chem. 271, 13981-13986[Abstract/Free Full Text]
  18. Irminger, J. C., Verchere, C. B., Meyer, K., and Halban, P. A. (1997) J. Biol. Chem. 272, 27532-27534[Abstract/Free Full Text]
  19. Varlamov, O., Fricker, L. D., Furukawa, H., Steiner, D. F., Langley, S. H., and Leiter, E. H. (1997) Endocrinology 138, 4883-4892[Abstract/Free Full Text]
  20. Fricker, L. D. (1988) Annu. Rev. Physiol. 50, 309-321[CrossRef][Medline] [Order article via Infotrieve]
  21. Fricker, L. D., Das, B., and Angeletti, R. H. (1990) J. Biol. Chem. 265, 2476-2482[Abstract/Free Full Text]
  22. Shennan, K. I. J., Taylor, N. A., and Docherty, K. (1994) J. Biol. Chem. 269, 18646-18650[Abstract/Free Full Text]
  23. Song, L., and Fricker, L. D. (1995) J. Biol. Chem. 270, 7963-7967[Abstract/Free Full Text]
  24. Fricker, L. D., and Devi, L. (1990) Anal. Biochem. 184, 21-27[CrossRef][Medline] [Order article via Infotrieve]
  25. Moore, H.-P. H., Gumbiner, B., and Kelly, R. B. (1983) Nature 302, 434-436[CrossRef][Medline] [Order article via Infotrieve]
  26. Mains, R. E., and May, V. (1988) J. Biol. Chem. 263, 7887-7894[Abstract/Free Full Text]
  27. Orci, L., Halban, P., Perrelet, A., Amherdt, M., Ravazzola, M., and Anderson, R. G. W. (1994) J. Cell Biol. 126, 1149-1156[Abstract/Free Full Text]
  28. von Zastrow, M., Castle, A. M., and Castle, J. D. (1989) J. Biol. Chem. 264, 6566-6571[Abstract/Free Full Text]
  29. Henomatsu, N., Yoshimori, T., Yamamoto, A., Moriyama, Y., and Tashiro, Y. (1993) Eur. J. Cell Biol. 62, 127-139[Medline] [Order article via Infotrieve]
  30. Demaurex, N., Furuya, W., D'Souza, S., Bonifacino, J. S., and Grinstein, S. (1998) J. Biol. Chem. 273, 2044-2051[Abstract/Free Full Text]
  31. Miesenbock, G., De Angelis, D. A., and Rothman, J. E. (1998) Nature 394, 192-195[CrossRef][Medline] [Order article via Infotrieve]
  32. Carnell, L., and Moore, H.-P. H. (1994) J. Cell Biol. 127, 693-706[Abstract/Free Full Text]
  33. Shen, F. S., and Loh, Y. P. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 5314-5319[Abstract/Free Full Text]
  34. Jacob, M., Laine, J., and LeBel, D. (1992) Biochem. Cell Biol. 70, 1105-1114[Medline] [Order article via Infotrieve]
  35. Yoo, S. H. (1994) J. Biol. Chem. 269, 12001-12006[Abstract/Free Full Text]
  36. Freedman, S. D., and Scheele, G. A. (1993) Eur. J. Cell Biol. 61, 229-238[Medline] [Order article via Infotrieve]
  37. Palmer, D. J., and Christie, D. L. (1992) J. Biol. Chem. 267, 19806-19812[Abstract/Free Full Text]
  38. Winkler, H. (1993) J. Anat. 183, 237-252


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.



This article has been cited by other articles:


Home page
Mol. Cell. ProteomicsHome page
Y. Brunner, Y. Coute, M. Iezzi, M. Foti, M. Fukuda, D. F. Hochstrasser, C. B. Wollheim, and J.-C. Sanchez
Proteomics Analysis of Insulin Secretory Granules
Mol. Cell. Proteomics, June 1, 2007; 6(6): 1007 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
J. A. Sobota, F. Ferraro, N. Back, B. A. Eipper, and R. E. Mains
Not All Secretory Granules Are Created Equal: Partitioning of Soluble Content Proteins
Mol. Biol. Cell, December 1, 2006; 17(12): 5038 - 5052.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. G. Venkatesh, D. J Cowley, and S.-U. Gorr
Differential aggregation properties of secretory proteins that are stored in exocrine secretory granules of the pancreas and parotid glands
Am J Physiol Cell Physiol, February 1, 2004; 286(2): C365 - C371.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. Hosaka, M. Suda, Y. Sakai, T. Izumi, T. Watanabe, and T. Takeuchi
Secretogranin III Binds to Cholesterol in the Secretory Granule Membrane as an Adapter for Chromogranin A
J. Biol. Chem., January 30, 2004; 279(5): 3627 - 3634.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
Y. P. LOH, A. MALDONADO, C. ZHANG, W. H. TAM, and N. CAWLEY
Mechanism of Sorting Proopiomelanocortin and Proenkephalin to the Regulated Secretory Pathway of Neuroendocrine Cells
Ann. N.Y. Acad. Sci., October 1, 2002; 971(1): 416 - 425.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. D. Blagoveshchenskaya, M. J. Hannah, S. Allen, and D. F. Cutler
Selective and Signal-dependent Recruitment of Membrane Proteins to Secretory Granules Formed by Heterologously Expressed von Willebrand Factor
Mol. Biol. Cell, May 1, 2002; 13(5): 1582 - 1593.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B.-J. Sankoorikal, Y. L. Zhu, M. E. Hodsdon, E. Lolis, and P. S. Dannies
Aggregation of Human Wild-Type and H27A-Prolactin in Cells and in Solution: Roles of Zn2+, Cu2+, and pH
Endocrinology, April 1, 2002; 143(4): 1302 - 1309.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
C. Zurzolo and C. Bowler
Exploring Bioinorganic Pattern Formation in Diatoms. A Story of Polarized Trafficking
Plant Physiology, December 1, 2001; 127(4): 1339 - 1345.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. C. Steveson, G. C. Zhao, H. T. Keutmann, R. E. Mains, and B. A. Eipper
Access of a Membrane Protein to Secretory Granules Is Facilitated by Phosphorylation
J. Biol. Chem., October 19, 2001; 276(43): 40326 - 40337.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
R. Kuliawat, D. Prabakaran, and P. Arvan
Proinsulin Endoproteolysis Confers Enhanced Targeting of Processed Insulin to the Regulated Secretory Pathway
Mol. Biol. Cell, June 1, 2000; 11(6): 1959 - 1972.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
M. D. Turner and P. Arvan
Protein Traffic from the Secretory Pathway to the Endosomal System in Pancreatic beta -Cells
J. Biol. Chem., May 5, 2000; 275(19): 14025 - 14030.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
D. E. Krantz, C. Waites, V. Oorschot, Y. Liu, R. I. Wilson, P. K. Tan, J. Klumperman, and R. H. Edwards
A Phosphorylation Site Regulates Sorting of the Vesicular Acetylcholine Transporter to Dense Core Vesicles
J. Cell Biol., April 17, 2000; 149(2): 379 - 396.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Cowley, Y. R. Moore, D. S. Darling, P. B. M. Joyce, and S.-U. Gorr
N- and C-terminal Domains Direct Cell Type-specific Sorting of Chromogranin A to Secretory Granules
J. Biol. Chem., March 10, 2000; 275(11): 7743 - 7748.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S.-U. Gorr, X. F. Huang, D. J. Cowley, R. Kuliawat, and P. Arvan
Disruption of disulfide bonds exhibits differential effects on trafficking of regulated secretory proteins
Am J Physiol Cell Physiol, July 1, 1999; 277(1): C121 - C131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Lee, Y. L. Zhu, J. E. Chang, and P. S. Dannies
Acquisition of Lubrol Insolubility, a Common Step for Growth Hormone and Prolactin in the Secretory Pathway of Neuroendocrine Cells
J. Biol. Chem., January 5, 2001; 276(1): 715 - 721.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. C. Bell-Parikh, B. A. Eipper, and R. E. Mains
Response of an Integral Granule Membrane Protein to Changes in pH
J. Biol. Chem., August 3, 2001; 276(32): 29854 - 29863.
[Abstract] [Full Text] [PDF]


<
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar